Industries > Pharma > Global Contraceptive Devices Market Forecast to 2027

Global Contraceptive Devices Market Forecast to 2027

Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD

PUBLISHED: 20 December 2017
PAGES: 186
PRODUCT CODE: PHA0271

Clear
WOOCS 2.2.1

The global contraceptive devices market is expected to grow at a CAGR of 7.5% in the first half of the forecast period. In 2016, the market was estimated at $12.1bn and dominated by the condoms submarket followed by the IUD submarket.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 186-page report you will receive 67 tables and 84 figures– all unavailable elsewhere.

The 186-page report provides clear detailed insight into the global contraceptive devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Contraceptive Devices Market Forecast to 2027

• This report also breaks down the revenue forecast for the global contraceptive devices market by type:
– Condoms:
Male and Female
– Diaphragms
– Sponges
– Vaginal Rigs
– Subdermal/Contraceptive Implants
– IUDs:
Copper IUD and Hormonal IUD

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– North America:
US & Canada
– Europe: the UK, Germany, France, Italy, Rest of Europe
– Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
Rest of the World (RoW): Latin America, Middle East & Africa

Global Contraceptive Devices Market Forecast to 2027

• This report discusses the SWOT Analysis and PEST Analysis of the global contraceptive devices market.

• Our study discusses the selected leading companies that are the major players in the global contraceptive devices market:
– Bayer AG
– Reckitt Benckiser Group plc
– Merck Sharp & Dohme Corp.
– Church & Dwight Co., Inc.
– Teva Pharmaceutical Industries, Ltd.
– Allergan plc
– Ansell Limited (Now Humanwell)
– The Female Health Company (a division of VERU Inc.)
– Karex Industries
– Mayer Laboratories
– Kessel Medintim GmbH
– Okamato Industries, Inc.
– Agile Therapeutics, Inc.
– Eurogine S.L.

Visiongain’s study is intended for anyone requiring commercial analyses for the global contraceptive devices market. You find data, trends and predictions.

Buy our report today Global Contraceptive Devices Market Forecast to 2027: Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Contraceptive Devices Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Contraceptive Devices Market Forecast to 2027


Latest Pharma news

Visiongain Publishes NGS-Based RNA Sequencing Market Report 2021-2031

The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.

11 May 2021

READ

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

READ

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

READ

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

READ

Categories